Transcriptional Regulation of NLRC4 Inflammasome Activation

NLRC4 炎症小体激活的转录调控

基本信息

项目摘要

ABSTRACT The NLRC4 inflammasome activation and the subsequent caspase-1-mediated maturation of IL-1β and IL-18 and pyroptosis are critical for protection against infection by bacterial pathogens such as Salmonella Typhimurium (S. Typhimurium). While much is known about how NLRC4 inflammasome is activated by sensing flagellin and components of type III secretion system (T3SS) by Naips, little is known about how the NLRC4 inflammasome activation is regulated. Epigenetic factor Brd4 plays a critical role in innate immune response by regulating inflammatory gene expression in macrophages. Brd4 stimulates gene expression by selective association with different transcription factors on promoters or enhancers. Our recent study demonstrate that mice with myeloid lineage-specific deletion of Brd4 were more sensitive to S. Typhimurium infection with reduced caspase-1 activation and IL-1β maturation in macrophages. More importantly, transcription of Naips and NLRC4 was down-regulated in Brd4-deficient mouse macrophages and Brd4 inhibited human macrophages. These exciting results suggest that Brd4 might modulate the activation of NLRC4 inflammasome by controlling the transcription of Naips and NLRC4, the two major components of NLRC4 inflammasome. Indeed, our most recent study demonstrate that Brd4 formed a complex with IRF8/PU.1 and bound to the IRF8 and PU.1 binding motifs on the promoters of Naips to maintain the expression of Naips in macrophages. However, how Brd4 regulates the expression of NLRC4 remains largely unknown. In this R03 proposal, we will investigate Brd4-mediated transcriptional regulation of NLRC4 expression and NLRC4 inflammasome activation. Completion of the proposed studies will provide new insights into the transcriptional regulation of NLRC4 inflammasome and provide new therapeutic approaches for NLRC4 inflammasome-mediated bacterial infection and immune disease by targeting Brd4.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lin-Feng Chen其他文献

Lin-Feng Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lin-Feng Chen', 18)}}的其他基金

Transcriptional Regulation of NLRC4 Inflammasome Activation
NLRC4 炎症小体激活的转录调控
  • 批准号:
    10560610
  • 财政年份:
    2022
  • 资助金额:
    $ 7.42万
  • 项目类别:
Antimicrobial activity of pH-activated polypeptides toward H. pylori
pH 激活多肽对幽门螺杆菌的抗菌活性
  • 批准号:
    8873154
  • 财政年份:
    2015
  • 资助金额:
    $ 7.42万
  • 项目类别:
Antimicrobial activity of pH-activated polypeptides toward H. pylori
pH 激活多肽对幽门螺杆菌的抗菌活性
  • 批准号:
    9056571
  • 财政年份:
    2015
  • 资助金额:
    $ 7.42万
  • 项目类别:
Transcriptional regulation of H. pylori-mediated gastric inflammation and cancer
幽门螺杆菌介导的胃炎症和癌症的转录调控
  • 批准号:
    8547187
  • 财政年份:
    2013
  • 资助金额:
    $ 7.42万
  • 项目类别:
Transcriptional regulation of H. pylori-mediated gastric inflammation and cancer
幽门螺杆菌介导的胃炎症和癌症的转录调控
  • 批准号:
    8726354
  • 财政年份:
    2013
  • 资助金额:
    $ 7.42万
  • 项目类别:
Transcriptional regulation of H. pylori-mediated gastric inflammation and cancer
幽门螺杆菌介导的胃炎症和癌症的转录调控
  • 批准号:
    8907751
  • 财政年份:
    2013
  • 资助金额:
    $ 7.42万
  • 项目类别:
Inactivation of RUNX3 by Helicobacter pylori and gastric cancer
幽门螺杆菌导致 RUNX3 失活与胃癌
  • 批准号:
    8485602
  • 财政年份:
    2012
  • 资助金额:
    $ 7.42万
  • 项目类别:
Inactivation of RUNX3 by Helicobacter pylori and gastric cancer
幽门螺杆菌导致 RUNX3 失活与胃癌
  • 批准号:
    8385337
  • 财政年份:
    2012
  • 资助金额:
    $ 7.42万
  • 项目类别:
NF-kB Signaling and H. Pylori-induced Gastric Disease
NF-kB 信号传导与幽门螺杆菌诱发的胃病
  • 批准号:
    7766467
  • 财政年份:
    2010
  • 资助金额:
    $ 7.42万
  • 项目类别:
NF-kB Signaling and H. Pylori-induced Gastric Disease
NF-kB 信号传导与幽门螺杆菌诱发的胃病
  • 批准号:
    8215750
  • 财政年份:
    2010
  • 资助金额:
    $ 7.42万
  • 项目类别:

相似海外基金

Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
  • 批准号:
    10574286
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
  • 批准号:
    10649771
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
  • 批准号:
    10644889
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
  • 批准号:
    MR/X031993/1
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
    Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
  • 批准号:
    EP/X014479/1
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
    Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
  • 批准号:
    10588846
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
  • 批准号:
    2306943
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
    Standard Grant
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
  • 批准号:
    10073241
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
    Grant for R&D
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
  • 批准号:
    10674221
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了